Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors determining extreme brain natriuretic peptide elevation.

Maya Guglin1, Rayan Hourani, Sridevi Pitta

  • 1Department of Medicine, Wayne State University, Detroit, MI 48201, USA. mguglin@gmail.com

Congestive Heart Failure (Greenwich, Conn.)
|June 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the differential hemodynamic effects of prostacyclins and sotatercept.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Cardiac Arrest From Sulfur Hexafluoride Contrast Anaphylaxis After Prior Perflutren Hypersensitivity.

JACC. Case reports·2026
Same author

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials.

JACC. Advances·2025
Same author

Mechano-Ino-Chronotropic Unloading in Cardiogenic Shock Due to Acute Myocardial Infarction-Hemodynamic Insights From Simulation Modeling.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

The Advanced Heart Failure Workforce Crisis: A Path Forward.

Journal of cardiac failure·2025
Same journal

Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction.

Congestive heart failure (Greenwich, Conn.)·2013
Same journal

Thiamine supplementation for the treatment of heart failure: a review of the literature.

Congestive heart failure (Greenwich, Conn.)·2013
Same journal

Preload reserve is restored in patients with decompensated chronic heart failure who respond to treatment.

Congestive heart failure (Greenwich, Conn.)·2013
Same journal

Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure.

Congestive heart failure (Greenwich, Conn.)·2013
Same journal

Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.

Congestive heart failure (Greenwich, Conn.)·2013
Same journal

Prognosis of morbid obesity patients with advanced heart failure.

Congestive heart failure (Greenwich, Conn.)·2013
See all related articles

Extremely high Brain Natriuretic Peptide (BNP) levels in heart failure patients may be linked more to kidney dysfunction than heart failure severity. Renal impairment appears to be a key factor in significantly elevated BNP readings.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Brain Natriuretic Peptide (BNP) levels are established indicators of heart failure severity.
  • The reasons behind extremely elevated BNP levels in some heart failure patients remain unclear.
  • Understanding factors contributing to high BNP is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To investigate the determinants of extremely high Brain Natriuretic Peptide (BNP) levels in heart failure patients.
  • To differentiate the contributions of heart failure severity versus renal function to elevated BNP.
  • To identify clinical factors associated with varying ranges of BNP elevation.

Main Methods:

  • Retrospective analysis of 179 heart failure patients with BNP levels in mild (500-1000 pg/mL), moderate (2000-3000 pg/mL), and high (4000-20,000 pg/mL) ranges.

Related Experiment Videos

  • Statistical analysis included unpaired t-tests and Pearson's correlation coefficient.
  • Adjustments were made for age, sex, and serum creatinine levels.

    • Main Results:

    • Patients with moderate BNP elevation showed more symptoms and advanced cardiac changes compared to those with mild elevation.
    • No significant differences in clinical characteristics were found between the moderate and high BNP level groups.
    • Serum creatinine levels positively correlated with BNP levels, while age and sex did not.

    Conclusions:

    • Extremely high BNP levels (4000-20,000 pg/mL) in heart failure patients are significantly influenced by renal dysfunction.
    • Renal impairment, rather than solely the severity of heart failure, appears to be a primary driver of markedly elevated BNP.
    • BNP levels should be interpreted in the context of kidney function in heart failure patients.